A network to run clinical trials could make finding new antibiotics cheaper and more efficient, according to a report we have published today.
Wellcome’s Director Jeremy Farrar says the commitment from world leaders at the United Nations (UN) General Assembly to tackle the rise in drug-resistant infections must now translate into measurable actions.
Drug resistance will be discussed at the UN General Assembly on Wednesday 21 September. Seth Berkley, CEO of Gavi, the Vaccine Alliance and Jeremy Farrar, Director of Wellcome, say the future of modern medicine and health security rest on the decisions we take now.
Wellcome is part of a major new transatlantic partnership to tackle the growing threat of drug-resistant infections. It will speed up the development of new antibiotics, diagnostics and other therapies.